Latest Asx News

American Tungsten & Antimony Ltd plans to unlock value by spinning out its Drummond Basin and NSW gold exploration assets into a new ASX-listed company, King Metals Limited, aiming to raise up to $6 million in an IPO.

Chimeric Therapeutics has raised $8.4 million to fully fund its lead CHM CDH17 CAR-T Phase 1/2 trial through Phase 1, while initiating a strategic reset to sharpen focus and reduce costs.

Metgasco has pushed back the deadline for Vintage Energy’s commitment to acquire its stake in the Odin and Vali Gas Fields, extending the timeline while keeping the overall transaction completion date intact.

Carnegie Clean Energy’s Spanish subsidiary has sold its 2025 Basque R&D tax deductions for €773,163, securing immediate funding to advance its ocean wave energy technology under the ACHIEVE Programme.

Neurizon Therapeutics has launched a A$24.2 million equity raise to fund the next phase of clinical trials for its lead drug NUZ-001 targeting ALS, supported by a global licensing deal and a flexible convertible note facility.

Elevate Uranium Ltd has expanded its global uranium resource to 169 million pounds of U3O8 through the acquisition of the Napperby Uranium Project and complementary assets from Core Lithium Ltd. This move consolidates its Central Australian portfolio and leverages its proprietary U-pgrade™ beneficiation technology.

Elevate Uranium has expanded its global uranium resource base to 169 million pounds of U3O8 through the strategic acquisition of the Napperby Uranium Project and complementary assets from Core Lithium. This move consolidates its Central Australian portfolio and leverages its proprietary U-pgrade™ beneficiation technology.

MRG Metals has raised $0.73 million through a placement to advance its rare earth and heavy mineral sands projects in Mozambique and South Africa, including a strategic acquisition and mining license progression.

MRG Metals has completed the acquisition of the Garies Rare Earth Project, a high-grade, magnet-rich rare earth asset in South Africa, significantly boosting its critical minerals portfolio. The deal positions MRG for rapid development with a clear pathway to early cashflow and complements its existing projects in Mozambique and the Adriano–Fotinho corridor.

OZZ Resources has entered a binding option agreement with Scorpion Minerals, offering an exclusive chance to acquire its key tenements for $2.6 million plus a gold production royalty. The deal awaits shareholder approval and hinges on several regulatory and operational conditions.

Kairos Minerals has reported compelling drill results from its Mt York Gold Project, highlighting significant gold intercepts that underpin an upcoming resource update scheduled for early 2026.

Invion Limited’s partner Hanlim Pharm, backed by South Korea’s government grant, has secured up to A$2 million in non-dilutive funding to advance preclinical studies of HL270 for oesophageal cancer, paving the way for human trials in Australia.